A urinary tract infection (UTI) is an infection caused by bacteria in part of the urinary tract. UTIs are among the most common infections in humans. Most UTIs only involve the urethra and bladder, in the lower tract. 

The global UTI Treatment market was valued to be 550 million USD in 2020. The UTI Treatment market size is anticipated to have grown with a CAGR of 14.55% in the coming years to reach 1,097 million USD in 2026 driven by marketing new brand drugs.

Europe is the largest market for UTI treatment which market share is 49.2% in 2020.  Following is North America, APAC, South America and MEA with 30.3%, 11.7%, 5.1% and 3.7% market share respectively.

Fosfomycin, Ceftolozane & Tazobactam, Cefixime, Meropenem & Vaborbactam and Nitrofurantoin are the most important drugs for UTI treatment. Here is the market share chart.